ARTICLE | Finance

Sofinnova steps up

Why Sofinnova Ventures upped the size of its tenth fund

October 24, 2016 7:00 AM UTC

With fewer crossover investors participating in its private biotech financings, Sofinnova Ventures has raised a new $650 million fund that will allow it to invest more capital per company to see them through key milestones.

Sofinnova Venture Partners Fund X closed on Oct. 17. It is the firm’s third dedicated life sciences fund and its largest to date. Fund IX, previously its biggest, closed at $500 million in 2014...

BCIQ Company Profiles

Sofinnova Investments Inc.